6 completed, 4 unknown, 1 terminated, 1 withdrawn. 12 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 6, Unknown 4, Terminated 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow Critically Ill: new trials by email Literature Review of Critically Ill trials Research Report on Critically Ill
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of PRUcalopride in Critically Ill Patients With Paralytic ILeus Prucalopride, Placebo - Paralytic Ileus, Critically Ill | Phase 3 | Unknown | Prince of Songkla University | 62 | 2017-07-01 | 2020-02-06 |
| Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients Spironolactone, Placebo - Critically Ill, Cancer | Phase 2 / Phase 3 | Unknown | Instituto Nacional de Cancerologia de Mexico | 24 | 2015-10-01 | 2017-01-04 |
| Hypocaloric Enteral Nutrition in the Critically Ill Patient Hipocaloric enteral nutrition, Normocaloric enteral nutrition - Critically Ill | Phase 3 | Completed | Lafrancol S.A. | 120 | 2013-12-01 | 2015-11-10 |
| Hypocaloric Nutrition in Critically Ill Patients Hypocaloric hyperproteic nutrition, Standard care - Critically Ill | Phase 3 | Completed | Lafrancol S.A. | 80 | 2011-08-01 | 2015-12-11 |
| The Clinical Role of Intravenous Glutamine in Trauma Patients Receiving Enteral Nutrition Dipeptiven, normal saline - Multiple Trauma, Critically Ill | Phase 3 | Unknown | Royal Brisbane and Women's Hospital | 88 | 2011-03-01 | 2012-05-24 |
| The Influence of Fluid Removal Using Continuous Venovenous Hemofiltration (CVVH) on Intra-abdominal Pressure and Kidney Function CVVH, ultrafiltration, ultrafiltration control group - Critically Ill, Intra-Abdominal Hypertension | Phase 3 | Withdrawn | University Hospital, Ghent | 2010-02-01 | 2022-12-15 | |
| Impact of SPN on Infection Rate, Duration of Mechanical Ventilation & Rehabilitation in ICU Patients SPN - Critically Ill | Phase 3 | Completed | University Hospital, Geneva | 305 | 2008-05-01 | 2013-04-19 |
| Forced Diuresis Versus Observation in Resolving Renal Failure After Haemofiltration in Critically Ill Patients Furosemide - Renal Failure, Critically Ill | Phase 3 | Terminated | Frisius Medisch Centrum | 72 | 2005-12-01 | 2007-04-19 |
| Hemodialysis Without Anticoagulation in Intensive Care Unit AN69 ST - Kidney Failure, Critically Ill | Phase 3 | Unknown | Centre Hospitalier Départemental | 120 | 2005-10-01 | 2007-10-03 |
| PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) Fragmin (Dalteparin) LMWH verus Unfractionated Heparin (UFH) - Critically Ill, Deep Venous Thrombosis | Phase 3 | Completed | Hamilton Health Sciences Corporation | 120 | 2003-02-01 | 2006-11-17 |
| N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography N-acetylcysteine, D5W Placebo - Contrast Induced Nephropathy, Critically Ill | Phase 2 / Phase 3 | Completed | Unity Health Toronto | 45 | 2002-08-01 | 2009-01-27 |
| Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim) Filgrastim - Acute Respiratory Failure, Critically Ill | Phase 2 / Phase 3 | Completed | Helsinki University Central Hospital | 59 | 1996-01-01 | 2012-10-29 |
Critical Illness (12) · Acute Kidney Injury (2) · Renal Insufficiency (2) · Hemorrhage (1) · Intestinal Pseudo-Obstruction (1) · Intra-Abdominal Hypertension (1) · Multiple Trauma (1) · Neoplasms (1) · Venous Thrombosis (1) · Wounds and Injuries (1)
Disease Attributes (12) · Pathologic Processes (12) · Pathological Conditions, Signs and Symptoms (12) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Kidney Diseases (4) · Male Urogenital Diseases (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Cardiovascular Diseases (2) · Renal Insufficiency (2) · Vascular Diseases (2) · Compartment Syndromes (1) · Digestive System Diseases (1) · Embolism and Thrombosis (1)
Acetylcysteine (1) · Dalteparin (1) · Filgrastim (1) · Furosemide (1) · Saline Solution (1) · Spironolactone (1) · Standard of Care (1) · Ultrafiltration (1) · alanylglutamine (1) · prucalopride (1)
Lafrancol S.A. (2) · Centre Hospitalier Départemental (1) · Frisius Medisch Centrum (1) · Hamilton Health Sciences Corporation (1) · Helsinki University Central Hospital (1) · Instituto Nacional de Cancerologia de Mexico (1) · Prince of Songkla University (1) · Royal Brisbane and Women's Hospital (1) · Unity Health Toronto (1) · University Hospital, Geneva (1) · University Hospital, Ghent (1)
Australia (2) · Canada (2) · Colombia (2) · Belgium (1) · Finland (1) · France (1) · Mexico (1) · Netherlands (1) · Switzerland (1) · Thailand (1)
Bertha M Cordova-Sanchez, MD (1) · Claudio M Martin, MD, FRCPC, MSc (1) · Deborah J Cook, MD (1) · Eric Hoste, MD, Phd (1) · Jeffrey Lipman, MBBCh, MD (1) · Kirsi-Maija Kaukonen, MD, PhD (1) · Peter van der Voort, MD, PhD, MSc (1) · Saul J Rugeles, MD (1) · Saul Rugeles, MD (1) · Sawangpong Jandee, Dr. (1) · Ville Pettila, MD, PhD (1)
PMID 11098963, PMID 15883741, PMID 16310609, PMID 19114909, PMID 22102646, PMID 23218813, PMID 23363492, PMID 39878152